Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0002 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0002 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0002 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.26 | 0.0003 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0003 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0003 |